These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Interactions of thyroxine and thyrocalcitonin in the rat. Cher SN; Chausm AB; Bellavia JV; Wallach S Endocrinology; 1970 Jun; 86(6):1337-46. PubMed ID: 5441870 [No Abstract] [Full Text] [Related]
49. [Changes in various parameters of calcium-phosphorus metabolism, roentgenomorphometric indicators in selected bones and results of the calcitonin test in patients with hyperthyroidism]. Gasińska T; Drozdz M; Izbicka M; Nawrat T; Beldzik A Endokrynol Pol; 1986; 37(2):75-84. PubMed ID: 3780573 [No Abstract] [Full Text] [Related]
50. [Malignant hypercalcemia during Basedow's disease]. Jaffiol C; Piperno M; Baldet L; Robin M; Mirouze J Sem Hop; 1975 Feb; 51(7):473-7. PubMed ID: 169580 [No Abstract] [Full Text] [Related]
51. Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin. Ralston SH; Alzaid AA; Gardner MD; Boyle IT Br Med J (Clin Res Ed); 1986 Jun; 292(6535):1549-50. PubMed ID: 3087513 [TBL] [Abstract][Full Text] [Related]
52. Hypophosphatemic rickets, hyperparathyroidism, and hyperthyroidism with hypercalcemia. Wangel AG; Pannall P Aust N Z J Med; 1985 Oct; 15(5):650-3. PubMed ID: 3867343 [TBL] [Abstract][Full Text] [Related]